Filed Nov. 11, 2024

Serial No. 79416326

Registered Nov. 18, 2025

Registration No. 8,026,660

Class Medicines for human purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; pharmaceutical preparations for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; drugs for medical purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; biological preparations for use in cell cultures for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; adjuvants for medical purposes; injectable solutions for medical purposes, namely, hyaluronidase in injectable form; aqueous solutions for medical purposes containing recombinant human hyaluronidase for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; biochemical drugs for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark